BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising developments across many clinical and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, more trusted choice for therapeutic use, notably in drug